Product Images Oxycodone Hcl

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Oxycodone Hcl NDC 10702-801 by Kvk-tech, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Table 1 - fig 1 table 1

Table 1 - fig 1 table 1

The text provides a conversion table for switching pediatric patients of 11 years and above to Oxycodone HCI extended-release tablets based on the prior opioid conversion factor. The table enlists the conversion factors for different opioids taken orally and parenterally. For patients receiving high-dose parenteral opioids, a more conservative conversion factor is advised.*

40 mg Container Label - fig 10 40 mg container label

40 mg Container Label - fig 10 40 mg container label

This is a prescription drug called Oxycodone Hydrochloride Extended-Release Tablets. Each container has 100 tablets that must be kept between 15°-30°C (S0°-85°F). The pharmacist must give the Medication Guide to each patient. The tablets should be swallowed whole and must not be cut, broken, chewed, or crushed.*

Table 2 - fig 2 table 2

Table 2 - fig 2 table 2

This is a table that shows the common adverse reactions (>5%) associated with extended-release Oxycodone HCI tablets compared to a placebo. The adverse reactions listed include constipation, nausea, somnolence, dizziness, pruritus, vomiting, headache, dry mouth, asthenia, and sweating. The numbers in parentheses indicate the percentage of individuals who experienced each adverse reaction.*

Table 3 - fig 3 table 3

Table 3 - fig 3 table 3

This is a table showing the incidence of adverse reactions reported by patients aged 11 to 16 years. It lists the number of patients in the study (N=140) and the percentage of those who experienced any adverse event. The most commonly reported adverse reactions were related to gastrointestinal disorders, such as vomiting, nausea, constipation, and diarrhea. General disorders and administration site conditions, such as fever, were also reported. Other adverse reactions included headaches, dizziness, and skin and subcutaneous tissue disorders, such as itching.*

Table 5 - fig 4 table 5

Table 5 - fig 4 table 5

This is a summary table of Maximum Drug Liking (Epa) data following intranasal administration, comparing the effects of Oxycodone HCI Original OxyContin and Oxycodone HCI (finely crushed or powdered) on VAS Scale. The table includes mean and median values for drug liking and "take drug" parameters, which were evaluated through a bipolar scale ranging from maximum negative response to maximum positive response.*

Figure 1 - fig 5 figure 1

Figure 1 - fig 5 figure 1

Structural Formula - fig 6 chemical structure

Structural Formula - fig 6 chemical structure

Table 6 - fig 7 table 6

Table 6 - fig 7 table 6

The text is a table showing mean values and coefficient of variation for different dosages and regimens of a drug, measured by AUC, Cmax, and Tmax. The drug is naltrexone and the table shows data for a single dose at 10mg, 20mg, and 40mg dosages. The data was collected while subjects received naltrexone, which may have enhanced absorption.*

10 mg Container Label - fig 8 10 mg container label

10 mg Container Label - fig 8 10 mg container label

This is a description of a medication called Oxycodone Hydrochloride Extended Release Tablets, which contains 10mg of the active ingredient. The tablets should be swallowed whole and not cut, chewed, broken or crushed. Pharmacies should dispense a medication guide to each patient and the tablets should be stored at temperatures between 25 and 30°C. The product is manufactured by KVK-Tech Pharmaceuticals and distributed by O.T. Hewtoun. The rest of the text contains illegible characters and is not available.*

20 mg Container Label - fig 9 20 mg container label

20 mg Container Label - fig 9 20 mg container label

This is a label for Oxycodone Hydrochloride Extended-Release Tablets with NDC code 10702-803-01. It contains 20mg of oxycodone hydrochloride and is dispensed in a container that should be stored at 15-30°C or 59-86°F. Patients should be given the accompanying medication guide and instructed to swallow the tablets whole without crushing, breaking, or dissolving them. It is manufactured by KVK Tech.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.